ILLUMINA INC (ILU.DE) Stock Fundamental Analysis
FRA:ILU - Deutsche Boerse Ag - US4523271090 - Common Stock - Currency: EUR
Overall ILU gets a fundamental rating of 4 out of 10. We evaluated ILU against 16 industry peers in the Life Sciences Tools & Services industry. ILU has only an average score on both its financial health and profitability. ILU has a decent growth rate and is not valued too expensively.
1. Profitability
1.1 Basic Checks
In the past year ILU was profitable.
In the past year ILU had a positive cash flow from operations.
In multiple years ILU reported negative net income over the last 5 years.
In the past 5 years ILU always reported a positive cash flow from operatings.
1.2 Ratios
ILU's Return On Assets of -19.39% is on the low side compared to the rest of the industry. ILU is outperformed by 87.50% of its industry peers.
ILU has a Return On Equity of -51.50%. This is amonst the worse of the industry: ILU underperforms 87.50% of its industry peers.
ILU's Return On Invested Capital of 9.56% is amongst the best of the industry. ILU outperforms 93.75% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.39% | ||
| ROE | -51.5% | ||
| ROIC | 9.56% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
Looking at the Operating Margin, with a value of 14.78%, ILU is in line with its industry, outperforming 56.25% of the companies in the same industry.
ILU's Operating Margin has declined in the last couple of years.
Looking at the Gross Margin, with a value of 65.44%, ILU belongs to the top of the industry, outperforming 100.00% of the companies in the same industry.
ILU's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.78% | ||
| PM (TTM) | N/A | ||
| GM | 65.44% |
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ILU is destroying value.
Compared to 1 year ago, ILU has about the same amount of shares outstanding.
The number of shares outstanding for ILU has been increased compared to 5 years ago.
ILU has a worse debt/assets ratio than last year.
2.2 Solvency
An Altman-Z score of 2.85 indicates that ILU is not a great score, but indicates only limited risk for bankruptcy at the moment.
ILU has a better Altman-Z score (2.85) than 62.50% of its industry peers.
The Debt to FCF ratio of ILU is 2.81, which is a good value as it means it would take ILU, 2.81 years of fcf income to pay off all of its debts.
ILU has a better Debt to FCF ratio (2.81) than 87.50% of its industry peers.
A Debt/Equity ratio of 0.63 indicates that ILU is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, ILU is in line with its industry, outperforming 50.00% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.81 | ||
| Altman-Z | 2.85 |
ROIC/WACC0.94
WACC10.18%
2.3 Liquidity
A Current Ratio of 1.78 indicates that ILU should not have too much problems paying its short term obligations.
ILU has a better Current ratio (1.78) than 75.00% of its industry peers.
ILU has a Quick Ratio of 1.42. This is a normal value and indicates that ILU is financially healthy and should not expect problems in meeting its short term obligations.
ILU has a better Quick ratio (1.42) than 87.50% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.42 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 181.61% over the past year.
The earnings per share for ILU have been decreasing by -17.93% on average. This is quite bad
The Revenue has decreased by -2.93% in the past year.
ILU shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.29% yearly.
EPS 1Y (TTM)181.61%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%514.29%
Revenue 1Y (TTM)-2.93%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-1.6%
3.2 Future
The Earnings Per Share is expected to grow by 23.52% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 4.80% on average over the next years.
EPS Next Y85.5%
EPS Next 2Y44.89%
EPS Next 3Y33.17%
EPS Next 5Y23.52%
Revenue Next Year-0.88%
Revenue Next 2Y1.78%
Revenue Next 3Y3.31%
Revenue Next 5Y4.8%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 31.98 indicates a quite expensive valuation of ILU.
ILU's Price/Earnings ratio is in line with the industry average.
When comparing the Price/Earnings ratio of ILU to the average of the S&P500 Index (28.10), we can say ILU is valued inline with the index average.
The Price/Forward Earnings ratio is 17.24, which indicates a rather expensive current valuation of ILU.
Compared to the rest of the industry, the Price/Forward Earnings ratio of ILU indicates a somewhat cheap valuation: ILU is cheaper than 62.50% of the companies listed in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 20.74, ILU is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.98 | ||
| Fwd PE | 17.24 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, ILU is valued a bit cheaper than 75.00% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, ILU is valued cheaper than 81.25% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 17.49 | ||
| EV/EBITDA | 12.89 |
4.3 Compensation for Growth
ILU's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as ILU's earnings are expected to grow with 33.17% in the coming years.
PEG (NY)0.37
PEG (5Y)N/A
EPS Next 2Y44.89%
EPS Next 3Y33.17%
5. Dividend
5.1 Amount
ILU does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:ILU (5/5/2025, 7:00:00 PM)
69.08
+1.58 (+2.34%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners104.43%
Inst Owner ChangeN/A
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap10.93B
Analysts73.55
Price Target102.93 (49%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)9.56%
Min EPS beat(2)-7.76%
Max EPS beat(2)26.88%
EPS beat(4)2
Avg EPS beat(4)19.35%
Min EPS beat(4)-60.91%
Max EPS beat(4)119.22%
EPS beat(8)6
Avg EPS beat(8)340.29%
EPS beat(12)9
Avg EPS beat(12)230.8%
EPS beat(16)13
Avg EPS beat(16)182.05%
Revenue beat(2)0
Avg Revenue beat(2)-1.04%
Min Revenue beat(2)-1.91%
Max Revenue beat(2)-0.18%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-1.91%
Max Revenue beat(4)0.91%
Revenue beat(8)4
Avg Revenue beat(8)-0.46%
Revenue beat(12)4
Avg Revenue beat(12)-1.2%
Revenue beat(16)8
Avg Revenue beat(16)0.55%
PT rev (1m)-15.62%
PT rev (3m)-33.88%
EPS NQ rev (1m)-0.03%
EPS NQ rev (3m)-6.62%
EPS NY rev (1m)-1.12%
EPS NY rev (3m)0.11%
Revenue NQ rev (1m)-0.28%
Revenue NQ rev (3m)-3.93%
Revenue NY rev (1m)-0.73%
Revenue NY rev (3m)-4.15%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.98 | ||
| Fwd PE | 17.24 | ||
| P/S | 2.84 | ||
| P/FCF | 17.49 | ||
| P/OCF | 14.82 | ||
| P/B | 5.23 | ||
| P/tB | 12.85 | ||
| EV/EBITDA | 12.89 |
EPS(TTM)2.16
EY3.13%
EPS(NY)4.01
Fwd EY5.8%
FCF(TTM)3.95
FCFY5.72%
OCF(TTM)4.66
OCFY6.75%
SpS24.35
BVpS13.22
TBVpS5.38
PEG (NY)0.37
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -19.39% | ||
| ROE | -51.5% | ||
| ROCE | 13.58% | ||
| ROIC | 9.56% | ||
| ROICexc | 12.86% | ||
| ROICexgc | 21.37% | ||
| OM | 14.78% | ||
| PM (TTM) | N/A | ||
| GM | 65.44% | ||
| FCFM | 16.22% |
ROA(3y)-22.28%
ROA(5y)-10.63%
ROE(3y)-46.16%
ROE(5y)-23.48%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y-6.48%
ROICexc growth 3YN/A
ROICexc growth 5Y-9.28%
OM growth 3YN/A
OM growth 5Y-11.47%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-2.07%
GM growth 5Y-1.23%
F-Score6
Asset Turnover0.69
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.63 | ||
| Debt/FCF | 2.81 | ||
| Debt/EBITDA | 1.49 | ||
| Cap/Depr | 36.16% | ||
| Cap/Sales | 2.93% | ||
| Interest Coverage | 7.78 | ||
| Cash Conversion | 83.7% | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.78 | ||
| Quick Ratio | 1.42 | ||
| Altman-Z | 2.85 |
F-Score6
WACC10.18%
ROIC/WACC0.94
Cap/Depr(3y)66.6%
Cap/Depr(5y)76.75%
Cap/Sales(3y)5.82%
Cap/Sales(5y)5.58%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)181.61%
EPS 3Y-25.65%
EPS 5Y-17.93%
EPS Q2Q%514.29%
EPS Next Y85.5%
EPS Next 2Y44.89%
EPS Next 3Y33.17%
EPS Next 5Y23.52%
Revenue 1Y (TTM)-2.93%
Revenue growth 3Y-1.15%
Revenue growth 5Y4.29%
Sales Q2Q%-1.6%
Revenue Next Year-0.88%
Revenue Next 2Y1.78%
Revenue Next 3Y3.31%
Revenue Next 5Y4.8%
EBIT growth 1Y1504.35%
EBIT growth 3YN/A
EBIT growth 5Y-7.67%
EBIT Next Year37.57%
EBIT Next 3Y18.78%
EBIT Next 5Y16.87%
FCF growth 1Y151.42%
FCF growth 3Y28.14%
FCF growth 5Y-3.38%
OCF growth 1Y75.1%
OCF growth 3Y15.37%
OCF growth 5Y-4.45%